Literature DB >> 23054605

Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex.

Claire L De-May1, Afia B Ali.   

Abstract

Endogenous cannabinoid type 1 (CB1) receptors demonstrate a cell type-specific expression and are potent modulators of synaptic transmission within the central nervous system. We aimed to investigate whether two classes of multipolar interneuron in the neocortex displayed a form of short-term synaptic plasticity, depolarization-induced suppression of inhibition (DSI), and whether the DSI was mediated by a common receptor. Paired whole cell recordings combined with biocytin labeling were performed between pyramidal cells and either multipolar adapting or multipolar nonadapting interneurons in layers II-IV of male Wistar rat (postnatal day 17-22) somatosensory cortex. Inhibitory postsynaptic potentials elicited by multipolar adapting interneurons were sensitive to DSI, which was blocked by the CB1 receptor antagonist AM-251 (8 μM), indicating that the suppression of inhibition was mediated by CB1 receptors. Two subpopulations of multipolar nonadapting interneuron-to-pyramidal cell connections were discovered on the basis of their susceptibility to DSI. Whereas 50% were insensitive to DSI, the remaining half were sensitive to DSI, which could not be prevented by AM-251. DSI at these connections was also insensitive to the group I (mGluRIa) and III metabotropic glutamate receptor antagonists (RS)-1-aminoindan-1,5-dicarboxylic acid (100 μM) and (RS)-α-cyclopropyl-4-phosphonophenylglycine (100 μM) and the group III agonist l-2-amino-4-phosphonobutanoate (50 μM). However, multipolar nonadapting interneuron-to-pyramidal cell connections were sensitive to the endocannabinoid anandamide (9 μM), mimicking the effects of DSI, which also could not be prevented by AM-251, implying a CB1 receptor-independent suppression of inhibition. These results reveal an interneuron type-specific modulation of synaptic transmission via CB receptors in the neocortex.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23054605      PMCID: PMC3545162          DOI: 10.1152/jn.00272.2012

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  40 in total

1.  Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition.

Authors:  Dale A Fortin; Joseph Trettel; Eric S Levine
Journal:  J Neurophysiol       Date:  2004-06-02       Impact factor: 2.714

Review 2.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.

Authors:  G Marsicano; B Lutz
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

4.  Target-dependent control of synaptic inhibition by endocannabinoids in the thalamus.

Authors:  Yan-Gang Sun; Chia-Shan Wu; Hui-Chen Lu; Michael Beierlein
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

5.  Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation.

Authors:  K Tsou; K Mackie; M C Sañudo-Peña; J M Walker
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  Cannabinoid CB1 receptors in rat medial prefrontal cortex are colocalized with calbindin- but not parvalbumin- and calretinin-positive GABA-ergic neurons.

Authors:  Krzysztof Wedzony; Agnieszka Chocyk
Journal:  Pharmacol Rep       Date:  2009 Nov-Dec       Impact factor: 3.024

7.  Effects of cannabinoids on endogenous K+ and Ca2+ currents in HEK293 cells.

Authors:  Clemente Vásquez; Ricardo A Navarro-Polanco; Miguel Huerta; Xóchitl Trujillo; Felipa Andrade; Benjamín Trujillo-Hernández; Leonardo Hernández
Journal:  Can J Physiol Pharmacol       Date:  2003-05       Impact factor: 2.273

8.  Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons.

Authors:  Dale A Fortin; Eric S Levine
Journal:  Cereb Cortex       Date:  2006-02-08       Impact factor: 5.357

Review 9.  Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects.

Authors:  Natalia Lozovaya; Rogier Min; Vera Tsintsadze; Nail Burnashev
Journal:  Cell Calcium       Date:  2009-08-13       Impact factor: 6.817

10.  Presynaptic Inhibition of GABAA receptor-mediated unitary IPSPs by cannabinoid receptors at synapses between CCK-positive interneurons in rat hippocampus.

Authors:  Afia B Ali
Journal:  J Neurophysiol       Date:  2007-06-13       Impact factor: 2.714

View more
  6 in total

1.  Short-term plasticity regulates the excitation/inhibition ratio and the temporal window for spike integration in CA1 pyramidal cells.

Authors:  Aundrea F Bartley; Lynn E Dobrunz
Journal:  Eur J Neurosci       Date:  2015-04-23       Impact factor: 3.386

2.  Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.

Authors:  Lillian J Brady; Aundrea F Bartley; Qin Li; Laura J McMeekin; John J Hablitz; Rita M Cowell; Lynn E Dobrunz
Journal:  Neuropharmacology       Date:  2016-07-29       Impact factor: 5.250

Review 3.  Endogenous cannabinoid signaling at inhibitory interneurons.

Authors:  Thomas J Younts; Pablo E Castillo
Journal:  Curr Opin Neurobiol       Date:  2013-12-28       Impact factor: 6.627

4.  Firing Frequency Maxima of Fast-Spiking Neurons in Human, Monkey, and Mouse Neocortex.

Authors:  Bo Wang; Wei Ke; Jing Guang; Guang Chen; Luping Yin; Suixin Deng; Quansheng He; Yaping Liu; Ting He; Rui Zheng; Yanbo Jiang; Xiaoxue Zhang; Tianfu Li; Guoming Luan; Haidong D Lu; Mingsha Zhang; Xiaohui Zhang; Yousheng Shu
Journal:  Front Cell Neurosci       Date:  2016-10-18       Impact factor: 5.505

5.  Interneuron Transcriptional Dysregulation Causes Frequency-Dependent Alterations in the Balance of Inhibition and Excitation in Hippocampus.

Authors:  Aundrea F Bartley; Elizabeth K Lucas; Lillian J Brady; Qin Li; John J Hablitz; Rita M Cowell; Lynn E Dobrunz
Journal:  J Neurosci       Date:  2015-11-18       Impact factor: 6.167

6.  Disrupted inhibitory plasticity and homeostasis in Fragile X syndrome.

Authors:  C A Cea-Del Rio; A Nunez-Parra; S M Freedman; J K Kushner; A L Alexander; D Restrepo; M M Huntsman
Journal:  Neurobiol Dis       Date:  2020-06-06       Impact factor: 5.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.